Nancy George

Dr. Nancy George

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Journal of Chemical Technology & Biotechnology
Verified
Journal Article
Closed access
PDF file
ADAbhrajit Debroy
Abhrajit Debroy
NGNancy George
Nancy George
GMGunjan Mukherjee
Gunjan Mukherjee

29 June 2023 in Environmental Pollution
Verified
Journal Article
Closed access
MYMohini Yadav
Mohini Yadav
NGNancy George
Nancy George
VDVagish Dwibedi
Vagish Dwibedi

23 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
TDTikam Chand Dakal
Tikam Chand Dakal
NGNancy George
Nancy George
CXCaiming Xu
Caiming Xu
Prashanth N SuravajhalaPrashanth N Suravajhala
Prashanth N Suravajhala
AAAbhishek A0bhishek
Abhishek A0bhishek
TIICs are critical components of the TME and are used to estimate prognostic and treatment responses in many malignancies. TIICs in the tumor microenvironment are assessed and quantified by categorizing immune cells into three subtypes: CD66b+ tumor-associated neutrophils (TANs), FoxP3+ regulatory T cells (Tregs), and CD163+ tumor-associated macrophages (TAMs). In addition, many cancers have tumor-infiltrating M1 and M2 macrophages, neutrophils (Neu), CD4+ T cells (T-helper), CD8+ T cells (T-cytotoxic), eosinophils, and mast cells. A variety of clinical treatments have linked tumor immune cell infiltration (ICI) to immunotherapy receptivity and prognosis. To improve the therapeutic effectiveness of immune-modulating drugs in a wider cancer patient population, immune cells and their interactions in the TME must be better understood. This study examines the clinicopathological effects of TIICs in overcoming tumor-mediated immunosuppression to boost antitumor immune responses and improve cancer prognosis. We successfully analyzed the predictive and prognostic usefulness of TIICs alongside TMB and ICI scores to identify cancer’s varied immune landscapes. Traditionally, immune cell infiltration was quantified using flow cytometry, immunohistochemistry, gene set enrichment analysis (GSEA), CIBERSORT, ESTIMATE, and other platforms that use integrated immune gene sets from previously published studies. We have also thoroughly examined traditional limitations and newly created unsupervised clustering and deconvolution techniques (SpatialVizScore and ProTICS). These methods predict patient outcomes and treatment responses better. These models may also identify individuals who may benefit more from adjuvant or neoadjuvant treatment. Overall, we think that the significant contribution of TIICs in cancer will greatly benefit postoperative follow-up, therapy, interventions, and informed choices on customized cancer medicines.

15 March 2022 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
ADAbhrajit Debroy
Abhrajit Debroy
MYMohini Yadav
Mohini Yadav
RDRadhika Dhawan
Radhika Dhawan
SDShubhankhi Dey
Shubhankhi Dey
NGNancy George
Nancy George

24 October 2023 in Chemical Papers
Verified
Journal Article
Closed access
PDF file
SGSubhi Gupta
Subhi Gupta
NGNancy George
Nancy George
MYMohini Yadav
Mohini Yadav
VDVagish Dwibedi
Vagish Dwibedi

1 November 2022 in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
Verified
Journal Article
Closed access
PDF file
ADArti Devi
Arti Devi
VDVagish Dwibedi
Vagish Dwibedi
NGNancy George
Nancy George
ZKZaved Ahmed Khan
Zaved Ahmed Khan